2 (±)-7, 8, 3′, 4′, 5′-pentamethoxyflavan (PMF), a synthetic flavan racemate, showed
growth inhibitory effect on various kinds of tumor cells. The present study is to investigate the …

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer
characterized by high invasion and metastasis rates. Xian-Ling-Lian-Xia formula (XLLX) is a …

Triple-negative breast cancer (TNBC) is the most aggressive molecular subtype of breast
cancer. Curcumol, as a natural small molecule compound, has potential anti-breast cancer …

Tumor metastasis remains the cause of 90% of cancer‐related deaths. Cancer stem cells
(CSC) are thought to be responsible for the aggressive and metastatic nature of triple …

Triple-negative breast cancer (TNBC) has become a serious threat to women's health.
Research on epigenetic drugs is gradually deepening and is expected to provide new …

Triple-negative breast cancer (TNBC) is associated with a high rate of early recurrence and
distant metastasis, frequent development of therapeutic resistance, and a poor prognosis …

Triple-negative breast cancer (TNBC) is defined as a group of primary breast cancers
lacking expression of estrogen, progesterone, and human epidermal growth factor receptor …

Triple negative breast cancer (TNBC) is considered to be the most difficult subtype of breast
cancer to treat because of its extremely prone to metastasis and the lack of targeted therapy …

Triple‐negative breast cancer (TNBC) is an aggressive subtype of breast cancer with a
metastatic nature. TNBC lacks the expression of the progesterone receptor, estrogen …

Phenotypic drug discovery (PDD) is an effective drug discovery approach by observation of
therapeutic effects on disease phenotypes, especially in complex disease systems. Triple …